Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) Operating Margin: 2020-2022

Historic Operating Margin for Therapeutics (RAPT) over the last 2 years, with Jun 2022 value amounting to -2,134.20%.

  • Therapeutics' Operating Margin fell 28368.00% to -2,134.20% in Q2 2022 from the same period last year, while for Jun 2022 it was -2,346.97%, marking a year-over-year decrease of 112145.00%. This contributed to the annual value of -5,618.53% for FY2022, which is 380345.00% down from last year.
  • Per Therapeutics' latest filing, its Operating Margin stood at -2,134.20% for Q2 2022, which was up 34.16% from -3,241.34% recorded in Q1 2022.
  • In the past 5 years, Therapeutics' Operating Margin registered a high of -954.25% during Q3 2020, and its lowest value of -3,241.34% during Q1 2022.
  • In the last 3 years, Therapeutics' Operating Margin had a median value of -1,622.42% in 2021 and averaged -1,721.86%.
  • Its Operating Margin has fluctuated over the past 5 years, first skyrocketed by 3,909bps in 2021, then plummeted by 188,610bps in 2022.
  • Over the past 3 years, Therapeutics' Operating Margin (Quarterly) stood at -1,004.99% in 2020, then tumbled by 138,046bps to -2,385.45% in 2021, then plummeted by 28,368bps to -2,134.20% in 2022.
  • Its last three reported values are -2,134.20% in Q2 2022, -3,241.34% for Q1 2022, and -2,385.45% during Q4 2021.